The effects of a constant intravenous infusion of naloxone in doses ranging from 3.2 to 6.4 mg/day were studied in a group of patients with anorexia nervosa. Patients showed a significantly greater weight gain during the infusion compared with the periods before and after naloxone. Plasma fJ-hydroxybutyrate and non-esterified fatty acid levels fell during the infusion. It is suggested that, in man, naloxone has an antilipolytic effect in vivo.
References
1.
DoleV.P., & MeinertzH. (1960) Journal of Biological Chemistry235, 2595–2599
2.
GhoshP., MillsI.H., & MooreR. (1977) Journal of Physiology271, 51–52P